| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/27/2013 | CN102989038A Preparation method and application of collagen-based composite corneal substitute capable of delivering endothelial inhibitory hormone |
| 03/27/2013 | CN102989012A Monitoring and modulating hgf/hgfr activity |
| 03/27/2013 | CN102989011A Medicine composition for treating liver caner and application thereof |
| 03/27/2013 | CN102989010A Porcine epidemic diarrhea virus genetic engineering subunit oral vaccine |
| 03/27/2013 | CN102989009A Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 03/27/2013 | CN102989008A Application of original protein converting enzyme 2 gene in preparation of medicaments for treating cancers |
| 03/27/2013 | CN102989007A Method for massively preparing midkine antisense oligodeoxynucleotide nano-liposomes for injection |
| 03/27/2013 | CN102988985A Use of miR-146a as blood vessel growth regulation target |
| 03/27/2013 | CN102988976A Hepatitis B virus core antigen-DNA (deoxyribonucleic acid) compound vaccine and preparation method thereof |
| 03/27/2013 | CN102988973A Nucleic acid vaccine for kio herpesvirus |
| 03/27/2013 | CN102988957A Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/27/2013 | CN102526762B Application of ALC1 to preparation of leukaemia drug resistance reversing agent and as drug-resistant leukaemia diagnosing reagent |
| 03/27/2013 | CN102321158B Polypeptide for preventing cell DNA synthesis and inhibiting cell proliferation and application |
| 03/27/2013 | CN102276731B High-motion-activity polypeptide capable of inhibiting cocaine induction and application thereof |
| 03/27/2013 | CN102234638B Modified maize ribosome-inactivating protein precursor and application as well as protein purification method thereof |
| 03/27/2013 | CN102199197B Polypeptides with function of self-assembled potassium channel and its application |
| 03/27/2013 | CN102198276B Application of chylomicron as liver targeting gene treatment vector |
| 03/27/2013 | CN102140466B Human miR-1825 antisense nucleic acid and application thereof |
| 03/27/2013 | CN102119925B Protein nano particle with tissue factor targeting property and preparation method and application thereof |
| 03/27/2013 | CN102031256B Human miR-485-5p antisense nucleic acid and application thereof |
| 03/27/2013 | CN101928347B Anti-carcinoembryonic-antigen (CEA) antibody and application thereof |
| 03/27/2013 | CN101897953B Non-invasive high-penetrability epidermal growth factor and application thereof |
| 03/27/2013 | CN101787368B siRNA for restraining Z38 gene expression of human being and application thereof in preparing breast-tumor resisting medicine |
| 03/27/2013 | CN101674853B Amino acid lipids and uses thereof |
| 03/27/2013 | CN101584869B Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring notch gene |
| 03/27/2013 | CN101563463B Intergenic sites between conserved genes in the genome of modified vaccinia ankara (MVA) vaccinia virus |
| 03/27/2013 | CN101484584B Production of isoprenoids |
| 03/27/2013 | CN101400697B Prevention/treatment of ichthyosis vulgaris, atopy and other disorders |
| 03/27/2013 | CN101111154B Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
| 03/26/2013 | US8404829 Predictive and therapeutic markers in ovarian cancer |
| 03/26/2013 | US8404826 Mycobacterial antigens expressed under low oxygen tension |
| 03/26/2013 | US8404654 Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes |
| 03/26/2013 | US8404653 Membrane bound stem cell factor therapy for ischemic heart |
| 03/26/2013 | US8404652 Substance which regulates the type-I collagen gene transcription regulating ability |
| 03/26/2013 | US8404253 Modified live (JMSO strain) Haemophilus parasuis vaccine |
| 03/26/2013 | US8404231 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 03/26/2013 | CA2463850C Remodeling of tissues and organs |
| 03/26/2013 | CA2379166C Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs |
| 03/26/2013 | CA2312000C Mammalian cytokine-like polypeptide-10 |
| 03/26/2013 | CA2262459C Gene involved in cadasil, method of diagnosis and therapeutic application |
| 03/21/2013 | WO2013040557A2 Rna engineered t cells for the treatment of cancer |
| 03/21/2013 | WO2013040504A2 Srpx for treatment of cancer |
| 03/21/2013 | WO2013040417A1 Amphiphilic cationic polymers for the delivery of therapeutic agents |
| 03/21/2013 | WO2013040295A2 Divalent-metal coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation |
| 03/21/2013 | WO2013039861A2 Engineered nucleic acids and methods of use thereof |
| 03/21/2013 | WO2013039857A1 Engineered nucleic acids and methods of use thereof |
| 03/21/2013 | WO2013039271A1 Brain-damage-induced frontal lobe dysfunction model animal and composition for alleviating frontal lobe dysfunction |
| 03/21/2013 | WO2013038907A1 Method for inhibiting cell growth, nucleic acid molecule having rna interference effect on nek10 variant gene, and anticancer agent |
| 03/21/2013 | WO2013015563A3 Electro-microneedle integrated body for in-situ cutaneous gene transfer and method of manufacturing same |
| 03/21/2013 | WO2012174412A3 Compositions targeting pkc-theta and uses and methods of treating pkc-theta pathologies, adverse immune responses and diseases |
| 03/21/2013 | WO2012166859A3 Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-strand rna virus infections |
| 03/21/2013 | WO2012135592A3 Theranostic imaging agents and methods of use |
| 03/21/2013 | WO2009137136A3 In vivo gene sensors |
| 03/21/2013 | US20130074201 Cancer-specific genetic rearrangements |
| 03/21/2013 | US20130072671 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 03/21/2013 | US20130072667 Use of rgm and its modulators |
| 03/21/2013 | US20130072548 Scalable Manufacturing Platform for Viral Vector Purification and Viral Vectors So Purified for Use in Gene Therapy |
| 03/21/2013 | US20130072547 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment of prevention of toll-like receptor-4-associated disorders |
| 03/21/2013 | US20130072441 Protease Inhibitors and Preventives or Remedies for Disease |
| 03/21/2013 | US20130072435 Tribonectins |
| 03/21/2013 | US20130071486 Acellular tissue matrices made from alpha-1,3-galactose-deficient tissue |
| 03/21/2013 | US20130071444 Amphiphilic Cationic Polymers and Methods of Use Thereof |
| 03/21/2013 | US20130071407 Methods for modulating hematopoiesis and vascular growth |
| 03/21/2013 | US20130071366 Insulin-like growth factor ii (igf-ii) binding factors |
| 03/21/2013 | US20130071365 Induced hepatocytes |
| 03/21/2013 | US20130071353 Antiviral Compounds and Methods of Use Thereof |
| 03/21/2013 | CA2848765A1 Immunotherapy and diagnosis of mucormycosis using coth |
| 03/21/2013 | CA2848740A1 Amphiphilic cationic polymers for the delivery of therapeutic agents |
| 03/20/2013 | EP2569432A2 Treatment of par4 related diseases by inhibition of natural antisense transcript to par4 |
| 03/20/2013 | EP2569276A1 Novel cationic lipids and methods of use thereof |
| 03/20/2013 | EP2569018A2 Humanized ttc and methods of use thereof |
| 03/20/2013 | EP2569017A1 Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1 |
| 03/20/2013 | EP2569003A2 Parathyroid hormone analogs and uses thereof |
| 03/20/2013 | EP2568958A1 Formulations of diluted genetic material and methods for making same |
| 03/20/2013 | CN1571834B Cell therapy method for the treatment of tumors |
| 03/20/2013 | CN1441841B Stimulation of cellular regeneration and differentiation in inner ear |
| 03/20/2013 | CN1371289B Gene therapy using TGF-beta |
| 03/20/2013 | CN102985543A Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4 |
| 03/20/2013 | CN102985436A Compositions and methods for the modification of gene transcription |
| 03/20/2013 | CN102985131A Medical devices for delivery of siRNA |
| 03/20/2013 | CN102985112A Pharmaceutical composition for treatment and prevention of herpesvirus infections |
| 03/20/2013 | CN102985095A Immunostimulatory and vaccine compositions |
| 03/20/2013 | CN102978278A Endogenous non-coding micro RNAs and uses thereof |
| 03/20/2013 | CN102978228A Recombination tiger gram pancreatic peptide supporter and preparation method and application thereof |
| 03/20/2013 | CN102978168A gM-negative EHV-mutants without heterologous elements |
| 03/20/2013 | CN102973953A MiRNA (micro ribose nucleic acid)-874 and application of miRNA-874antisense nucleotide |
| 03/20/2013 | CN102973952A DNA (deoxyribonucleic acid) vaccine for expressing infectious bursal disease virus polyprotein gene VP243, as well as construction method and application thereof |
| 03/20/2013 | CN102973951A Koi herpesvirus ORF25 nucleic acid vaccine |
| 03/20/2013 | CN102973950A PRAME and WT1 bivalent tumor DNA vaccine |
| 03/20/2013 | CN102382832B SiRNA for inhibiting expression of PAR-1 gene and application thereof |
| 03/20/2013 | CN101863963B Helicobacter pylori antigen epitope polypeptide and application thereof |
| 03/20/2013 | CN101619305B Antihuman CD52 monoclonal antibody hybridoma cell line, monoclonal antibody, engineered antibody, carrier, reagent kit and application thereof |
| 03/20/2013 | CN101432291B Chimeric adenoviral vectors |
| 03/20/2013 | CN101384282B Method for production of a transformed cell |
| 03/19/2013 | US8399650 Mycobacterial antigens expressed during latency |
| 03/19/2013 | US8399628 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof |
| 03/19/2013 | US8399613 Tumour-associated peptides that bind to MHC molecules |
| 03/19/2013 | US8399423 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| 03/19/2013 | US8399422 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 03/19/2013 | US8399233 Histone deacetylases, and uses related thereto |